Women's Health Trial Tracker — 2018

Name: Women's Health Trial Tracker
Creator: 1 Women’s Health
License: United States government work; public domain unless the source record says otherwise.

Record	Record Date	Vuga Group	Change Status	Recency Days
Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies	01/04/2018	OBSERVATIONAL	not-comparable	3,201.75
Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study)	01/05/2018	INTERVENTIONAL	not-comparable	3,200.75
Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)	01/09/2018	INTERVENTIONAL	not-comparable	3,196.75
Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes	01/10/2018	OBSERVATIONAL	not-comparable	3,195.75
Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer	01/17/2018	INTERVENTIONAL	not-comparable	3,188.75
Effects of Simvastatin on Uterine Leiomyoma Size	01/17/2018	INTERVENTIONAL	not-comparable	3,188.75
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome	01/17/2018	INTERVENTIONAL	not-comparable	3,188.75
Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)	01/23/2018	INTERVENTIONAL	not-comparable	3,182.75
Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study	01/24/2018	OBSERVATIONAL	not-comparable	3,181.75
Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery	01/24/2018	OBSERVATIONAL	not-comparable	3,181.75
Perioperative Music Listening on Anxiety, Pain, Analgesia Use and Patient Satisfaction	01/30/2018	INTERVENTIONAL	not-comparable	3,175.75
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD	01/31/2018	INTERVENTIONAL	not-comparable	3,174.75
Accelerated iTBS for Post Partum Depression	01/31/2018	INTERVENTIONAL	not-comparable	3,174.75
Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy	02/01/2018	INTERVENTIONAL	not-comparable	3,173.75
Study Looking at Biomarkers in Ovarian Cancer	02/05/2018	INTERVENTIONAL	not-comparable	3,169.75
Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma	02/05/2018	INTERVENTIONAL	not-comparable	3,169.75
Exercise, Fitness and Tumor Profiling in Breast Cancer Patients	02/07/2018	OBSERVATIONAL	not-comparable	3,167.75
Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer	02/08/2018	INTERVENTIONAL	not-comparable	3,166.75
An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer	02/12/2018	INTERVENTIONAL	not-comparable	3,162.75
Sweden Cancerome Analysis Network - Breast (SCAN-B) Coupled to Psychological Resilience	02/13/2018	OBSERVATIONAL	not-comparable	3,161.75
Ovarian Function After Use of Various Hemostatic Techniques During Treatment for Endometrioma	02/13/2018	INTERVENTIONAL	not-comparable	3,161.75
Identification of New Prognostic Markers for Breast Cancer.	02/19/2018	OBSERVATIONAL	not-comparable	3,155.75
Accelerated Partial Breast Irradiation Study	02/19/2018	INTERVENTIONAL	not-comparable	3,155.75
Endometrial Cancer Lymphadenectomy Trial	02/19/2018	INTERVENTIONAL	not-comparable	3,155.75
Comprehensive Lifestyle Change To Prevent Breast Cancer	02/27/2018	INTERVENTIONAL	not-comparable	3,147.75
The PREDICT Registry:	02/28/2018	OBSERVATIONAL	not-comparable	3,146.75
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients	02/28/2018	INTERVENTIONAL	not-comparable	3,146.75
Older Breast Cancer Patients: Risk for Cognitive Decline	03/01/2018	OBSERVATIONAL	not-comparable	3,145.75
Omission of Radiation in Patients With Her-2 Positive Breast Cancer	03/09/2018	INTERVENTIONAL	not-comparable	3,137.75
Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC	03/13/2018	INTERVENTIONAL	not-comparable	3,133.75
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors	03/13/2018	INTERVENTIONAL	not-comparable	3,133.75
Individual Approach in Gynecological Cancer Brachytherapy	03/15/2018	INTERVENTIONAL	not-comparable	3,131.75
PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer	03/19/2018	INTERVENTIONAL	not-comparable	3,127.75
ASA in Prevention of Ovarian Cancer (STICs and STONEs)	03/29/2018	INTERVENTIONAL	not-comparable	3,117.75
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy	04/03/2018	INTERVENTIONAL	not-comparable	3,112.75
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer	04/05/2018	INTERVENTIONAL	not-comparable	3,110.75
MRI Characterization of Mammographically Detected DCIS	04/11/2018	OBSERVATIONAL	not-comparable	3,104.75
Autologous Ovarian Tissue Transplantation	04/12/2018	INTERVENTIONAL	not-comparable	3,103.75
Clinical Cohort Study on the Endocrinology and Vaginal/Endometrial Microbiome of the Luteal Phase in Assisted Reproduction	04/25/2018	OBSERVATIONAL	not-comparable	3,090.75
LimPrOn: Limburg Pre-eclampsia Investigation	04/26/2018	INTERVENTIONAL	not-comparable	3,089.75
Maternal Smoking Cessation and Pediatric Obesity Prevention	05/02/2018	INTERVENTIONAL	not-comparable	3,083.75
Follow-up in Gynecological Cancer Survivors	05/04/2018	OBSERVATIONAL	not-comparable	3,081.75
Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer	05/08/2018	INTERVENTIONAL	not-comparable	3,077.75
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy	05/11/2018	INTERVENTIONAL	not-comparable	3,074.75
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery	05/14/2018	INTERVENTIONAL	not-comparable	3,071.75
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy	05/14/2018	INTERVENTIONAL	not-comparable	3,071.75
Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer	05/16/2018	INTERVENTIONAL	not-comparable	3,069.75
Gestational Diabetes and Pharmacotherapy (GAP)	05/17/2018	INTERVENTIONAL	not-comparable	3,068.75
Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma	05/22/2018	INTERVENTIONAL	not-comparable	3,063.75
Induction Chemotherapy Followed by Standard Therapy in Cervical Cancer With Aortic Lymph Node Spread	05/23/2018	INTERVENTIONAL	not-comparable	3,062.75
Ultrasound Identification Automation Study	05/24/2018	OBSERVATIONAL	not-comparable	3,061.75
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry	05/25/2018	OBSERVATIONAL	not-comparable	3,060.75
The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons	05/29/2018	OBSERVATIONAL	not-comparable	3,056.75
Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer	06/06/2018	INTERVENTIONAL	not-comparable	3,048.75
Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants	06/06/2018	INTERVENTIONAL	not-comparable	3,048.75
Quality of Life and Fertility of Patient With Deep Surgical Endometriosis: a Prospective Cohort	06/14/2018	OBSERVATIONAL	not-comparable	3,040.75
Efficacy of Metoclopramide in Poor Ovarian Response IVF Patients	06/18/2018	INTERVENTIONAL	not-comparable	3,036.75
A Registry of Intra-Operative Radiation Therapy (IORT) Using the Xoft ® Axxent ® eBx ™ System Patients	06/19/2018	OBSERVATIONAL	not-comparable	3,035.75
Birth Cohort Study of China Medical University	06/19/2018	OBSERVATIONAL	not-comparable	3,035.75
GammaPod Registry and Quality of Life Nomogram	06/19/2018	OBSERVATIONAL	not-comparable	3,035.75
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers	06/20/2018	INTERVENTIONAL	not-comparable	3,034.75
Gynecologic Extramammary Paget's Disease	06/20/2018	OBSERVATIONAL	not-comparable	3,034.75
Vaginal Microbiome Exposure and Immune Responses in C-section Infants	06/26/2018	INTERVENTIONAL	not-comparable	3,028.75
CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer	06/26/2018	INTERVENTIONAL	not-comparable	3,028.75
Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging	06/26/2018	OBSERVATIONAL	not-comparable	3,028.75
Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer	06/27/2018	INTERVENTIONAL	not-comparable	3,027.75
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job	06/28/2018	INTERVENTIONAL	not-comparable	3,026.75
Chronic Effect of Fasting	06/29/2018	INTERVENTIONAL	not-comparable	3,025.75
Breast Aesthetics by Three Dimensional Measures	07/06/2018	OBSERVATIONAL	not-comparable	3,018.75
Study of the Safety and Effectiveness of Motiva Implants®	07/09/2018	INTERVENTIONAL	not-comparable	3,015.75
Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using Gammapod	07/10/2018	INTERVENTIONAL	not-comparable	3,014.75
Accelerated Partial Breast Irradiation With IMRT in Early Breast Cancer	07/11/2018	INTERVENTIONAL	not-comparable	3,013.75
The Effect of Membrane Sweeping on the Delivery Time and the Need of Induction in Term Pregnancy	07/19/2018	INTERVENTIONAL	not-comparable	3,005.75
Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer	07/19/2018	INTERVENTIONAL	not-comparable	3,005.75
Baby's First Years	07/20/2018	INTERVENTIONAL	not-comparable	3,004.75
Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer	07/23/2018	INTERVENTIONAL	not-comparable	3,001.75
Mineral Status in Pregnant Women	07/26/2018	OBSERVATIONAL	not-comparable	2,998.75
A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer	07/27/2018	INTERVENTIONAL	not-comparable	2,997.75
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF	07/27/2018	INTERVENTIONAL	not-comparable	2,997.75
Non-contrast DWI for Supplemental Screening	07/31/2018	OBSERVATIONAL	not-comparable	2,993.75
A Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational Diabetes	07/31/2018	INTERVENTIONAL	not-comparable	2,993.75
SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer	08/03/2018	INTERVENTIONAL	not-comparable	2,990.75
Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.	08/06/2018	INTERVENTIONAL	not-comparable	2,987.75
Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC	08/06/2018	INTERVENTIONAL	not-comparable	2,987.75
Image Guided IMRT, Radiochemotherapy and MRI-based IGABT in Locally Advanced Cervical Cancer	08/06/2018	INTERVENTIONAL	not-comparable	2,987.75
Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer	08/07/2018	OBSERVATIONAL	not-comparable	2,986.75
Development of Advanced Double Intravenous Vasopressor Automated (ADIVA) System	08/08/2018	INTERVENTIONAL	not-comparable	2,985.75
PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer	08/09/2018	OBSERVATIONAL	not-comparable	2,984.75
Cohort of Patients With Pelvic Gynecological Cancer: Constitution of a Collection of Biological Samples With Radioclinical Characterization	08/09/2018	OBSERVATIONAL	not-comparable	2,984.75
Comparative Antiresorptive Efficacy Discontinuation of Denosumab	08/09/2018	INTERVENTIONAL	not-comparable	2,984.75
Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)	08/10/2018	INTERVENTIONAL	not-comparable	2,983.75
CFI-400945 in Patients With Advanced/Metastatic Breast Cancer	08/10/2018	INTERVENTIONAL	not-comparable	2,983.75
Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms	08/10/2018	OBSERVATIONAL	not-comparable	2,983.75
Study of the Physiology of Pre-eclampsia and Vascular IUGR With Constitution of a Biological Collection	08/10/2018	OBSERVATIONAL	not-comparable	2,983.75
Maternal Outcomes Following Manual Lysis of the Placenta.	08/13/2018	INTERVENTIONAL	not-comparable	2,980.75
Maternal Grandmothers in the Born in Guangzhou Cohort Study	08/16/2018	OBSERVATIONAL	not-comparable	2,977.75
Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS	08/16/2018	INTERVENTIONAL	not-comparable	2,977.75
Multidisciplinary Treatment of Chronic Vulvar Pain	08/21/2018	INTERVENTIONAL	not-comparable	2,972.75
Post-operative Emesis and Pain Outcomes After Cesarean Delivery	08/24/2018	OBSERVATIONAL	not-comparable	2,969.75
Improving Sleep Quality During Pregnancy Using an Oral Appliance	08/24/2018	INTERVENTIONAL	not-comparable	2,969.75
Partial Breast Versus no Irradiation for Women With Early Breast Cancer	08/24/2018	INTERVENTIONAL	not-comparable	2,969.75
Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients	08/29/2018	INTERVENTIONAL	not-comparable	2,964.75
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib	08/29/2018	INTERVENTIONAL	not-comparable	2,964.75
Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone	09/07/2018	INTERVENTIONAL	not-comparable	2,955.75
Investigating the Structured Use of Ultrasound Scanning for Fetal Growth	09/07/2018	OBSERVATIONAL	not-comparable	2,955.75
Intravenous Estrogen in Kidney Transplant Study	09/10/2018	INTERVENTIONAL	not-comparable	2,952.75
Postpartum Low-Dose Aspirin and Preeclampsia	09/12/2018	INTERVENTIONAL	not-comparable	2,950.75
AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma	09/12/2018	INTERVENTIONAL	not-comparable	2,950.75
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients	09/14/2018	INTERVENTIONAL	not-comparable	2,948.75
Laser Vaginal Treatment for SUI	09/14/2018	INTERVENTIONAL	not-comparable	2,948.75
Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy	09/14/2018	INTERVENTIONAL	not-comparable	2,948.75
My Personalized Breast Screening	09/14/2018	INTERVENTIONAL	not-comparable	2,948.75
Michigan Contraceptive Access, Research, and Evaluation Study: Phase 1	09/17/2018	INTERVENTIONAL	not-comparable	2,945.75
Ribociclib and Letrozole Treatment in Ovarian Cancer	09/17/2018	INTERVENTIONAL	not-comparable	2,945.75
Fetoscopic Endoluminal Tracheal Occlusion	09/17/2018	INTERVENTIONAL	not-comparable	2,945.75
Evaluation of an Online, Remote Cognitive Battery for Use in Cancer Survivorship	09/17/2018	OBSERVATIONAL	not-comparable	2,945.75
RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer	09/18/2018	INTERVENTIONAL	not-comparable	2,944.75
Dietary Management of Gestational Diabetes	09/21/2018	INTERVENTIONAL	not-comparable	2,941.75
Preoperative Virtual Reality to Reduce Pain on Gynaecologic Patients Undergoing Surgery	09/26/2018	INTERVENTIONAL	not-comparable	2,936.75
An Ultrasound Guided Automated Spinal Landmark Identification System	09/27/2018	INTERVENTIONAL	not-comparable	2,935.75
Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH)	09/28/2018	INTERVENTIONAL	not-comparable	2,934.75
Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP	10/02/2018	OBSERVATIONAL	not-comparable	2,930.75
mHealth Integrated Model of Hypertension, Diabetes and Antenatal Care in India and Nepal	10/09/2018	INTERVENTIONAL	not-comparable	2,923.75
Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia	10/11/2018	INTERVENTIONAL	not-comparable	2,921.75
Tocotrienols for Obesity of Postmenopausal Women	10/15/2018	INTERVENTIONAL	not-comparable	2,917.75
A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors	10/16/2018	INTERVENTIONAL	not-comparable	2,916.75
PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Paget's Disease of the Vulva (EMPV).	10/19/2018	INTERVENTIONAL	not-comparable	2,913.75
Robot-assisted Approach to Cervical Cancer	10/25/2018	INTERVENTIONAL	not-comparable	2,907.75
Exploring Respiratory Health Outcomes From Sustained Use of Efficient Cookstoves	11/01/2018	INTERVENTIONAL	not-comparable	2,900.75
A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer	11/02/2018	INTERVENTIONAL	not-comparable	2,899.75
Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation Therapy	11/05/2018	INTERVENTIONAL	not-comparable	2,896.75
Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing Treatment	11/06/2018	INTERVENTIONAL	not-comparable	2,895.75
Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast Cancer	11/06/2018	INTERVENTIONAL	not-comparable	2,895.75
Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer	11/07/2018	INTERVENTIONAL	not-comparable	2,894.75
Peer Approaches to Lupus Self-management	11/07/2018	INTERVENTIONAL	not-comparable	2,894.75
Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer	11/08/2018	INTERVENTIONAL	not-comparable	2,893.75
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients	11/09/2018	INTERVENTIONAL	not-comparable	2,892.75
An mHealth Intervention to Improve Outcomes for Women With HIV/AIDS	11/13/2018	INTERVENTIONAL	not-comparable	2,888.75
The Role of Estrogen in the Neurobiology of Eating Disorders	11/14/2018	INTERVENTIONAL	not-comparable	2,887.75
A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer	11/15/2018	INTERVENTIONAL	not-comparable	2,886.75
Cardiovascular Disease Risk in Women With Endometriosis	11/19/2018	INTERVENTIONAL	not-comparable	2,882.75
3D Animation and Models to Aid Management of Fetal CDH	11/23/2018	OBSERVATIONAL	not-comparable	2,878.75
Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital	11/23/2018	INTERVENTIONAL	not-comparable	2,878.75
Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance	11/28/2018	OBSERVATIONAL	not-comparable	2,873.75
Collection of Donated Placenta for Isolation of Mitochondria for Research and for Future Use in Mitochondrial Augmentation Therapies	12/03/2018	OBSERVATIONAL	not-comparable	2,868.75
AMBULAPSE STUDY Feasibility Study on Laparoscopic Double-mesh Sacrocolpopexy With or Without Robotic Assistance, in Female Patients Presenting With Symptomatic Pelvic Organ Prolapse, Based on an Outpatient Treatment Model.	12/05/2018	INTERVENTIONAL	not-comparable	2,866.75
Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making	12/05/2018	INTERVENTIONAL	not-comparable	2,866.75
LAparoscopic Preventive PRErectal Mesh	12/05/2018	INTERVENTIONAL	not-comparable	2,866.75
Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube	12/11/2018	INTERVENTIONAL	not-comparable	2,860.75
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)	12/11/2018	INTERVENTIONAL	not-comparable	2,860.75
Post Operative Cognitive Dysfunction After Breast Surgery	12/13/2018	OBSERVATIONAL	not-comparable	2,858.75
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise	12/14/2018	OBSERVATIONAL	not-comparable	2,857.75
Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic Tumors	12/17/2018	INTERVENTIONAL	not-comparable	2,854.75
Metabolic and Bone Changes After Adjuvant Cancer Treatments in Early Non-metastatic Breast Cancer	12/24/2018	OBSERVATIONAL	not-comparable	2,847.75
Vaginal Cuff Brachytherapy Fractionation Study	12/24/2018	INTERVENTIONAL	not-comparable	2,847.75
Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule	12/24/2018	INTERVENTIONAL	not-comparable	2,847.75
Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer	12/26/2018	INTERVENTIONAL	not-comparable	2,845.75
One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer	12/27/2018	INTERVENTIONAL	not-comparable	2,844.75